Tetrahydroxystilbene glycoside improves endothelial dysfunction and hypertension in obese rats: The role of omentin-1

Biochem Pharmacol. 2021 Apr:186:114489. doi: 10.1016/j.bcp.2021.114489. Epub 2021 Feb 27.

Abstract

Rationale: Hypertension in obesity has become a major threat for public health. Omentin-1, a novel adipokine, is down-regulated in obesity. Tetrahydroxystilbene glycoside (TSG) is the main ingredient extracted from Polygonum multiflorum Thunb (PMT), a traditional Chinese medicinal herb safely used for protecting cardiovascular systems over bimillennium. This study aims to examine (i) the impact of omentin-1 downregulation on obesity-related hypertension in murine models and the underlying mechanisms; (ii) whether tetrahydroxystilbene glycoside (TSG) improved endothelial dysfunction and obesity-associated hypertension via the increase of omentin-1.

Methods: (TSG-treated) male Zucker diabetic fatty (ZDF) rats and omentin-1 knockout (OMT-/-) mice were used. In vitro, human umbilical vein endothelial cells (HUVECs) and mature adipocytes differentiated from human visceral preadipocyte (HPA-v) were maintained in a co-culture system.

Results: TSG was the main active component of PMT reducing systolic blood pressure and improving endothelial vasodilation. Fortnight-TSG treatment (100 mg/kg/day) increased serum omentin-1 level, also activated Akt/eNOS signaling and enhanced NO bioactivity; decreased expression of NOX2 and p22phox, suppressed production of superoxide and peroxynitrite anion. OMT-/- mice showed elevated blood pressure and impaired endothelial vasorelaxation, whereas hypotensive effect of TSG was blunted. In co-culture system, TSG incubation promoted binding of peroxisome proliferator-activated receptor-γ (PPAR-γ) and Itln-1 promoter in adipocytes, activated Akt/eNOS/NO signaling and attenuated oxidative/nitrative stress in HUVECs. Suppression of Itln-1 with siRNA significantly blocked the protective effect of TSG in vitro.

Conclusions: Down-regulation of omentin-1 induces endothelial dysfunction and hypertension in obesity. TSG treatment (at least partially) increases omentin-1 via promoting binding of PPAR-γ and Itln-1 promoter in adipose tissues, subsequently exerts protective effects on endothelial function via activating Akt/eNOS/NO signaling and attenuating oxidative/nitrative stress. These results suggest that TSG could be developed as a promising anti-hypertension agent that protects against endothelial dysfunction and obesity-associated cardiovascular diseases.

Keywords: Endothelial dysfunction; Hypertension; Obesity; Omentin-1; Oxidative/nitrative stress; Tetrahydroxystilbene glycoside.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines / biosynthesis*
  • Cytokines / deficiency*
  • Cytokines / genetics
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • GPI-Linked Proteins / biosynthesis*
  • GPI-Linked Proteins / deficiency*
  • GPI-Linked Proteins / genetics
  • Glucosides / metabolism
  • Glucosides / pharmacology
  • Glucosides / therapeutic use*
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / genetics
  • Hypertension / metabolism
  • Lectins / biosynthesis*
  • Lectins / deficiency*
  • Lectins / genetics
  • Male
  • Mice
  • Mice, Knockout
  • Rats
  • Rats, Zucker
  • Stilbenes / metabolism
  • Stilbenes / pharmacology
  • Stilbenes / therapeutic use*

Substances

  • 2',3',4',5'-tetrahydroxystilbene-2-O-beta-D-glucoside
  • Cytokines
  • GPI-Linked Proteins
  • Glucosides
  • Itln1 protein, mouse
  • Lectins
  • Stilbenes